Recent strategies in the development of taxane anticancer drugs

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.10, Iss.6, 2000-06, pp. : 869-889

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Advances in the New Generation Taxane Anticancer Agents

Medicinal Chemistry, Vol. 1, Iss. 2, 2005-01 ,pp. : 125-139

Bentham Science Publishers

Access to resources Recommend Favorite

Strategies on the Development of Small Molecule Anticancer Drugs for Targeted Therapy

Mini Reviews in Medicinal Chemistry, Vol. 11, Iss. 7, 2011-06 ,pp. : 611-624

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in the Development of Dual Topoisomerase I and II Inhibitors as Anticancer Drugs

Current Medicinal Chemistry, Vol. 17, Iss. 35, 2010-12 ,pp. : 4270-4290

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in the development of hybrid anticancer drugs

By Fortin Sébastien

Expert Opinion on Drug Discovery, Vol. 8, Iss. 8, 2013-11 ,pp. : 1029-1047

Informa Healthcare

Access to resources Recommend Favorite

Innovations and strategies for the development of anticancer vaccines

By Chamberlain R.S. Kaufman H.

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 4, 2000-05 ,pp. : 603-614

Informa Healthcare

Access to resources Recommend Favorite